Ms Andrea Reid > Dechert LLP > Boston, United States > Lawyer Profile

Dechert LLP
BOSTON, MA 02110-2605
United States
Andrea Reid photo

Work Department

Intellectual Property


Andrea L.C. Reid, co-lead of Dechert’s Global Life Sciences Practice, counsels established and start-up clients in all sectors of the biotech and pharmaceutical industries on developing intellectual property issues, policies, patent portfolio management and filing strategies at all phases of the business cycle. Ms. Reid’s ability to develop IP strategies for U.S. and European clients has resulted in more than US$10 billion in acquisition and investor/partner funding. With more than 30 years of experience working in the pharmaceutical industry, she has extensive experience in all areas of drug discovery through drug development. She draws on this experience when prosecuting patent applications and preparing patentability, validity and infringement opinions involving active pharmaceutical ingredients, manufacturing syntheses and formulations. She regularly represents clients on specialty issues relating to organic chemistry, small molecule pharmaceuticals and polymorph intellectual property.


Boston University, B.S., Chemistry, 1987 University of Massachusetts Lowell, M.S., Chemistry, 1996 Suffolk University Law School, J.D., Intellectual Property, 2006, with distinction

Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

With experience advising life sciences clients of all sizes, Dechert LLP acts on a mix of transactions, litigation and corporate financings. Its corporate arm has acted on numerous IPOs for clinical-stage biopharma teams, as well as follow on and early funding rounds. Other corporate work includes M&A, monetization agreements, and business immigration. Disputes are a key part of the team’s workload, advising on product liability cases, antitrust disputes, and IP litigation, with an emphasis on small molecules cases. The team is co-led by Boston-based IP advisor Andrea Reid and New York-based David S Rosenthal, who advises on financings. New York-based Katherine Helm is a key name for patent litigation. Boston-based Brenda Sharton is also noteworthy for her advice to Moderna on EU data privacy breaches.

United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)

Recommended for being ‘diligent, comprehensive, collaborative, nimble, and resourceful’, Dechert LLP‘s practice is widely recognized as a highly-competitive player in the life sciences sector, regularly acting for pharmaceutical and biotechnology companies in a wide variety of matters, including patent portfolio development for pre-public and discovery stage clients, the management of international patent portfolios, multi-million dollar transactions, and disputes brought before the USPTO. Boston’s Andrea Reid and Andrew Wilkins, who joined the firm in February 2021 from Lathrop GPM, share the helm of the practice. Chad E. Davis, also in Boston, is another name to note. Carl Morales left the firm in October 2021.